Your browser doesn't support javascript.
loading
Longitudinal minimal residual disease assessment in multiple myeloma patients in complete remission - results from the NMSG flow-MRD substudy within the EMN02/HO95 MM trial.
Schmitz, Alexander; Brøndum, Rasmus Froberg; Johnsen, Hans Erik; Mellqvist, Ulf-Henrik; Waage, Anders; Gimsing, Peter; Op Bruinink, Davine Hofste; van der Velden, Vincent; van der Holt, Bronno; Hansson, Markus; Andersen, Niels Frost; Frølund, Ulf Christian; Helleberg, Carsten; Schjesvold, Fredrik H; Ahlberg, Lucia; Gulbrandsen, Nina; Andreasson, Bjorn; Lauri, Birgitta; Haukas, Einar; Bødker, Julie Støve; Roug, Anne Stidsholt; Bøgsted, Martin; Severinsen, Marianne T; Gregersen, Henrik; Abildgaard, Niels; Sonneveld, Pieter; Dybkær, Karen.
Afiliação
  • Schmitz A; Department of Haematology, Aalborg University Hospital, Forskningens Hus, Søndre Skovvej 15, DK-9000, Aalborg, Denmark.
  • Brøndum RF; Clinical Cancer Research Center, Aalborg University Hospital, Aalborg, Denmark.
  • Johnsen HE; Department of Haematology, Aalborg University Hospital, Forskningens Hus, Søndre Skovvej 15, DK-9000, Aalborg, Denmark.
  • Mellqvist UH; Clinical Cancer Research Center, Aalborg University Hospital, Aalborg, Denmark.
  • Waage A; Department of Haematology, Aalborg University Hospital, Forskningens Hus, Søndre Skovvej 15, DK-9000, Aalborg, Denmark.
  • Gimsing P; Clinical Cancer Research Center, Aalborg University Hospital, Aalborg, Denmark.
  • Op Bruinink DH; Department of Clinical Medicine, Aalborg University, Aalborg, Denmark.
  • van der Velden V; For the Nordic Myeloma Study Group (NMSG).
  • van der Holt B; For the Nordic Myeloma Study Group (NMSG).
  • Hansson M; South Elvsborg Hospital, Boras, Sweden.
  • Andersen NF; For the Nordic Myeloma Study Group (NMSG).
  • Frølund UC; Norwegian University of Science and Technology and St. Olav's University Hospital, Trondheim, Norway.
  • Helleberg C; For the Nordic Myeloma Study Group (NMSG).
  • Schjesvold FH; Department of Haematology, University of Copenhagen, Copenhagen, Denmark.
  • Ahlberg L; Department of Immunology, Erasmus MC, University Medical Center, Rotterdam, The Netherlands.
  • Gulbrandsen N; Department of Immunology, Erasmus MC, University Medical Center, Rotterdam, The Netherlands.
  • Andreasson B; Department of Immunology, Erasmus MC, University Medical Center, Rotterdam, The Netherlands.
  • Lauri B; HOVON Data Center, Department of Haematology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
  • Haukas E; For the Nordic Myeloma Study Group (NMSG).
  • Bødker JS; Skane University Hospital, Lund, Sweden.
  • Roug AS; For the Nordic Myeloma Study Group (NMSG).
  • Bøgsted M; Department of Haematology, Aarhus University Hospital, Aarhus, Denmark.
  • Severinsen MT; For the Nordic Myeloma Study Group (NMSG).
  • Gregersen H; Department of Haematology, Sjællands Universitetshospital, Roskilde, Denmark.
  • Abildgaard N; For the Nordic Myeloma Study Group (NMSG).
  • Sonneveld P; Department of Hematology, Herlev Hospital, Herlev, Denmark.
  • Dybkær K; For the Nordic Myeloma Study Group (NMSG).
BMC Cancer ; 22(1): 147, 2022 Feb 05.
Article em En | MEDLINE | ID: mdl-35123422
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Mortalidade / Geral / Tipos_de_cancer / Outros_tipos / Tratamento Base de dados: MEDLINE Assunto principal: Neoplasia Residual / Citometria de Fluxo / Mieloma Múltiplo Tipo de estudo: Clinical_trials / Diagnostic_studies / Evaluation_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Female / Humans / Male / Middle aged País/Região como assunto: Europa Idioma: En Revista: BMC Cancer Assunto da revista: NEOPLASIAS Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Dinamarca
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Mortalidade / Geral / Tipos_de_cancer / Outros_tipos / Tratamento Base de dados: MEDLINE Assunto principal: Neoplasia Residual / Citometria de Fluxo / Mieloma Múltiplo Tipo de estudo: Clinical_trials / Diagnostic_studies / Evaluation_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Female / Humans / Male / Middle aged País/Região como assunto: Europa Idioma: En Revista: BMC Cancer Assunto da revista: NEOPLASIAS Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Dinamarca